Plasma thrombosis markers following cerebral infarction in African Americans

Askiel Bruno, Joseph P. McConnell, Stanley N. Cohen, Gretchen E. Tietjen, De Juran Richardson, Philip B. Gorelick, Nils U. Bang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Our aim was to evaluate plasma thrombosis markers following non-cardioembolic cerebral infarction for possible correlation with recurrent vascular events. We enrolled 88 subjects treated with antiplatelet drugs and followed them for 2 years with plasma fibrinogen, F1.2, TAT, and D-dimer measurements at baseline, 6, 12, and 24 months. Vascular events were cerebral infarction, myocardial infarction, or vascular death. Recurrent vascular events occurred in 13 subjects and did not correlate with any of the markers, at baseline or during follow-up. There were large within-subject fluctuations in fibrinogen, F1.2, and TAT levels and the D-dimer changed between normal and abnormal in 48% of subjects. This pilot study did not detect a trend for a difference in plasma fibrinogen, F1.2, TAT, or D-dimer levels between African Americans with and without recurrent vascular events following cerebral infarction. Large within-subject fluctuations in these marker levels may limit their usefulness as predictors of vascular events in clinical practice.

Original languageEnglish (US)
Pages (from-to)73-77
Number of pages5
JournalThrombosis Research
Volume115
Issue number1-2
DOIs
StatePublished - Jan 1 2005
Externally publishedYes

Fingerprint

Cerebral Infarction
African Americans
Blood Vessels
Thrombosis
Fibrinogen
Platelet Aggregation Inhibitors
Myocardial Infarction
fibrin fragment D

Keywords

  • Atherosclerosis
  • Infarction
  • Plasma thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Bruno, A., McConnell, J. P., Cohen, S. N., Tietjen, G. E., Richardson, D. J., Gorelick, P. B., & Bang, N. U. (2005). Plasma thrombosis markers following cerebral infarction in African Americans. Thrombosis Research, 115(1-2), 73-77. https://doi.org/10.1016/j.thromres.2004.06.043

Plasma thrombosis markers following cerebral infarction in African Americans. / Bruno, Askiel; McConnell, Joseph P.; Cohen, Stanley N.; Tietjen, Gretchen E.; Richardson, De Juran; Gorelick, Philip B.; Bang, Nils U.

In: Thrombosis Research, Vol. 115, No. 1-2, 01.01.2005, p. 73-77.

Research output: Contribution to journalArticle

Bruno, A, McConnell, JP, Cohen, SN, Tietjen, GE, Richardson, DJ, Gorelick, PB & Bang, NU 2005, 'Plasma thrombosis markers following cerebral infarction in African Americans', Thrombosis Research, vol. 115, no. 1-2, pp. 73-77. https://doi.org/10.1016/j.thromres.2004.06.043
Bruno A, McConnell JP, Cohen SN, Tietjen GE, Richardson DJ, Gorelick PB et al. Plasma thrombosis markers following cerebral infarction in African Americans. Thrombosis Research. 2005 Jan 1;115(1-2):73-77. https://doi.org/10.1016/j.thromres.2004.06.043
Bruno, Askiel ; McConnell, Joseph P. ; Cohen, Stanley N. ; Tietjen, Gretchen E. ; Richardson, De Juran ; Gorelick, Philip B. ; Bang, Nils U. / Plasma thrombosis markers following cerebral infarction in African Americans. In: Thrombosis Research. 2005 ; Vol. 115, No. 1-2. pp. 73-77.
@article{bd191797888549cba6fda5b65780a815,
title = "Plasma thrombosis markers following cerebral infarction in African Americans",
abstract = "Our aim was to evaluate plasma thrombosis markers following non-cardioembolic cerebral infarction for possible correlation with recurrent vascular events. We enrolled 88 subjects treated with antiplatelet drugs and followed them for 2 years with plasma fibrinogen, F1.2, TAT, and D-dimer measurements at baseline, 6, 12, and 24 months. Vascular events were cerebral infarction, myocardial infarction, or vascular death. Recurrent vascular events occurred in 13 subjects and did not correlate with any of the markers, at baseline or during follow-up. There were large within-subject fluctuations in fibrinogen, F1.2, and TAT levels and the D-dimer changed between normal and abnormal in 48{\%} of subjects. This pilot study did not detect a trend for a difference in plasma fibrinogen, F1.2, TAT, or D-dimer levels between African Americans with and without recurrent vascular events following cerebral infarction. Large within-subject fluctuations in these marker levels may limit their usefulness as predictors of vascular events in clinical practice.",
keywords = "Atherosclerosis, Infarction, Plasma thrombosis",
author = "Askiel Bruno and McConnell, {Joseph P.} and Cohen, {Stanley N.} and Tietjen, {Gretchen E.} and Richardson, {De Juran} and Gorelick, {Philip B.} and Bang, {Nils U.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/j.thromres.2004.06.043",
language = "English (US)",
volume = "115",
pages = "73--77",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "1-2",

}

TY - JOUR

T1 - Plasma thrombosis markers following cerebral infarction in African Americans

AU - Bruno, Askiel

AU - McConnell, Joseph P.

AU - Cohen, Stanley N.

AU - Tietjen, Gretchen E.

AU - Richardson, De Juran

AU - Gorelick, Philip B.

AU - Bang, Nils U.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Our aim was to evaluate plasma thrombosis markers following non-cardioembolic cerebral infarction for possible correlation with recurrent vascular events. We enrolled 88 subjects treated with antiplatelet drugs and followed them for 2 years with plasma fibrinogen, F1.2, TAT, and D-dimer measurements at baseline, 6, 12, and 24 months. Vascular events were cerebral infarction, myocardial infarction, or vascular death. Recurrent vascular events occurred in 13 subjects and did not correlate with any of the markers, at baseline or during follow-up. There were large within-subject fluctuations in fibrinogen, F1.2, and TAT levels and the D-dimer changed between normal and abnormal in 48% of subjects. This pilot study did not detect a trend for a difference in plasma fibrinogen, F1.2, TAT, or D-dimer levels between African Americans with and without recurrent vascular events following cerebral infarction. Large within-subject fluctuations in these marker levels may limit their usefulness as predictors of vascular events in clinical practice.

AB - Our aim was to evaluate plasma thrombosis markers following non-cardioembolic cerebral infarction for possible correlation with recurrent vascular events. We enrolled 88 subjects treated with antiplatelet drugs and followed them for 2 years with plasma fibrinogen, F1.2, TAT, and D-dimer measurements at baseline, 6, 12, and 24 months. Vascular events were cerebral infarction, myocardial infarction, or vascular death. Recurrent vascular events occurred in 13 subjects and did not correlate with any of the markers, at baseline or during follow-up. There were large within-subject fluctuations in fibrinogen, F1.2, and TAT levels and the D-dimer changed between normal and abnormal in 48% of subjects. This pilot study did not detect a trend for a difference in plasma fibrinogen, F1.2, TAT, or D-dimer levels between African Americans with and without recurrent vascular events following cerebral infarction. Large within-subject fluctuations in these marker levels may limit their usefulness as predictors of vascular events in clinical practice.

KW - Atherosclerosis

KW - Infarction

KW - Plasma thrombosis

UR - http://www.scopus.com/inward/record.url?scp=9644281623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644281623&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2004.06.043

DO - 10.1016/j.thromres.2004.06.043

M3 - Article

VL - 115

SP - 73

EP - 77

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 1-2

ER -